Skip to main content
Clinical Trials/RBR-10c6922p
RBR-10c6922p
Recruiting
未知

Cardiorrespiratory telerabilitation for patients post covid-19 hospitalization in brazil: randomized clinical trial

niversidade Federal de São Carlos0 sitesAugust 3, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal de São Carlos
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2021
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de São Carlos

Eligibility Criteria

Inclusion Criteria

  • Patients aged 35 to 85 years; after hospital discharge caused by COVID\-19 infection (diagnosis confirmed or highly suspected by laboratory or tomographic examination); hemodynamically stable (absence of severe arrhythmias; uncontrolled arterial hypertension), absence of the use of tracheostomy, and against indication to perform the proposed tests (such as previous orthopedic disease, unstable angina, and acute myocardial infarction in the previous 6 months, severe valve disease, etc); not bedridden, being under medical supervision; who are not being treated for diseases severe chronic conditions (such as cancer, chronic renal failure, neuromuscular diseases) who have access to a cell phone or computer and who have limitations in physical capacity (80% or less in the performance of the proposed physical tests).

Exclusion Criteria

  • Patients with cognitive balance deficit, with the risk of falling when performing the proposed physical tests and giving up participation.

Outcomes

Primary Outcomes

Not specified

Similar Trials